SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-000620
Filing Date
2021-01-08
Accepted
2021-01-08 08:19:25
Documents
8
Period of Report
2021-01-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20210106.htm 8-K 41758
2 EX-5.1 clsd-ex51_15.htm EX-5.1 10868
3 EX-99.1 clsd-ex991_61.htm EX-99.1 254992
4 EX-99.2 clsd-ex992_18.htm EX-99.2 142205
5 EX-99.3 clsd-ex993_14.htm EX-99.3 11652
6 GRAPHIC gm4gmtmcms1o000002.jpg GRAPHIC 3000
7 GRAPHIC gm4gmtmcms1o000001.jpg GRAPHIC 3000
8 GRAPHIC gsxpqb4k4hf5000001.jpg GRAPHIC 2833
  Complete submission text file 0001564590-21-000620.txt   475228
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 21515706
SIC: 2834 Pharmaceutical Preparations